KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
KYTH was delisted on the 30th of September, 2015.
126 hedge funds and large institutions have $1.14B invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2015 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 53 increasing their positions, 24 reducing their positions, and 14 closing their positions.
143% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 14
121% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 24
73% more capital invested
Capital invested by funds: $663M → $1.14B (+$481M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
19% more funds holding
Funds holding: 106 → 126 (+20)
32% less call options, than puts
Call options by funds: $8.86M | Put options by funds: $13M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$22.2M |
| 2 |
BM
Bridger Management
New York
|
+$18.7M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$17.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.6M |
| 5 |
HM
HealthCor Management
New York
|
+$14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$20.4M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
-$14.1M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$9.44M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$9.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.99M |
KYTH Hedge Fund Activity: Q1 2015 in Review
126 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q1 2015, worth a combined $1.14B — up 73% from $663M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new KYTH positions and 14 closed out — a net gain of 20 holders — while 53 added to existing stakes and 24 trimmed.
The largest buyer was Jennison Associates, adding an estimated $22.2M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $20.4M sold.
- 126 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q1 2015, up from 106 in Q4 2014.
- Funds reported $1.14B of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q1 2015, up 73% quarter-over-quarter.
- 34 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q1 2015 and 14 closed out, a net change of +20 holders.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q1 2015 was Jennison Associates, an estimated $22.2M added.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q1 2015 was Adage Capital Partners, an estimated $20.4M sold.
Based on aggregated 13F filings for Q1 2015.